A biodegradable device (BioSTAR™) for atrial septal defect closure in children

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 2, 2010, Pages 241-245

  Morgan, Gareth ^a   Lee, Kyong Jin ^a   Chaturvedi, Rajiv ^a   Benson, Lee ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Atrial septal defect; Device occlusion; Pediatric interventional cardiology

Indexed keywords

ARTICLE; BIODEGRADABLE IMPLANT; CLINICAL ARTICLE; FLUOROSCOPY; FOLLOW UP; HEART ATRIUM SEPTUM DEFECT; HUMAN; PATENT FORAMEN OVALE; PERCUTANEOUS CORONARY INTERVENTION; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; ADOLESCENT; CHILD; CHILD, PRESCHOOL; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; ONTARIO; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; SEPTAL OCCLUDER DEVICE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955131047     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22517     Document Type: Article

References (28)

1. Du ZD, Cao QL, Rhodes J, Heitschmidt M, Hijazi ZM. Choice of device size and results of transcatheter closure of atrial septal defect using the Amplatzer septal occluder. J Interv Cardiol 2002;15:287-292. (Pubitemid 35015099)
2. Rastogi N, Smeeton NC, Qureshi SA. Factors related to successful transcatheter closure of atrial septal defects using the Amplatzer Septal Occluder. Pediatr Cardiol 2009;30:888-892.
3. Yew G, Wilson NJ. Transcatheter atrial septal defect closure with the Amplatzer septal occluder: Five-year follow-up. Cath Cardiovasc Interv 2005;64:193-196. (Pubitemid 40189187)
4. El-Said HG, Moore JW. Erosion by the Amplatzer septal occluder: Experienced operator opinions at odds with manufacturer recommendations? Cath Cardiovasc Interv 2009;73:925-930.
5. Cecconi M, Quarti A, Bianchini F, Bucari S, Costantini C, Giovagnoni A, Perna GP. Late cardiac perforation after transcatheter closure of patent foramen ovale. Ann Thorac Surg 2006;81:e29-e30.
6. Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk. Cath Cardiovasc Interv 2004;63:496-502. (Pubitemid 39578516)
7. Wilson NJ, Smith J, Prommete B, O'Donnell C, Gentles TL, Ruygrok PN. Transcatheter closure of secundum atrial septal defects with the Amplatzer septal occluder in adults and children-follow-up closure rates, degree of mitral regurgitation and evolution of arrhythmias. Heart Lung Circ 2008;17:318-324.
8. Giardini A, Donti A, Sciarra F, Bronzetti G, Mariucci E, Picchio FM. Long-term incidence of atrial fibrillation and flutter after transcatheter atrial septal defect closure in adults. Int J Cardiol 2009;134:47-51.
9. Silversides CK, Haberer K, Siu SC, Webb GD, Benson LN, McLaughlin PR, Harris L. Predictors of atrial arrhythmias after device closure of secundum type atrial septal defects in adults. Am J Cardiol 2008;101:683-687. (Pubitemid 351625096)
10. Melzer, Michitsch, Konak, Schaefers, Bertsch T. Nitinol in magnetic resonance imaging. Minim Invasive Ther Allied Tech 2004;13:261-271.
11. Beerbaum P, Körperich H, Esdorn H, Blanz U, Barth P, Hartmann J, Gieseke J, Meyer H. Atrial septal defects in pediatric patients: Noninvasive sizing with cardiovascular MR imaging. Radiology 2003;228:361-369. (Pubitemid 36910073)
12. Santoro G, Pascotto M, Sarubbi B, Cappelli Bigazzi M, Calvanese R, Iacono C, Pisacane C, Palladino MT, Pacileo G, Russo MG, Calabrò R. Early electrical and geometric changes after percutaneous closure of large atrial septal defect. Am J Cardiol 2004;93:876-880. (Pubitemid 38429600)
13. Sigler M, Jux C. Biocompatibility of septal defect closure devices. Heart 2000;93:444-449
14. Sigler M, Jux C, Ewert P. Histopathological workup of an Amplatzer atrial septal defect occluder after surgical removal. Pediatr Cardiol 2006;27:775-776. (Pubitemid 44915421)
15. Zilberman MV, Stone DM, Du W, Turner DR, Delius RE. Surgical vs. percutaneous atrial septal defect closure: Remote effects on left ventricular diastolic function. Int J Cardiol 2008;128:269-271. (Pubitemid 352033587)
16. Rao PS, Sideris EB. Long-term complications of ASD closure devices. Cath Cardiovasc Interv 2007;69:924-925.
17. Carminati M, Chessa M, Butera G, Bini RM, Giusti S, Festa P, Spadoni I, Redaelli S, Hausdorf G. Transcatheter closure of atrial septal defects with the STARFlex device: Early results and follow-up. J Interv Cardiol 2001;14:319-324. (Pubitemid 32531897)
18. Nugent AW, Britt A, Gauvreau K, Piercey GE, Lock JE, Jenkins KJ. Device closure rates of simple atrial septal defects optimized by the STARFlex device. J Am Coll Cardiol 2006;48:538-544. (Pubitemid 44093967)
19. Boccalandro F, Muench A, Salloum J, Awadalla H, Carter C, Barasch E, Smalling RW. Interatrial defect sizing by intracardiac and transesophageal echocardiography compared with fluoroscopic measurements in patients undergoing percutaneous transcatheter closure. Cath Cardiovasc Interv 2004;62:415-420. (Pubitemid 38868885)
20. Hausdorf G. StarFlex ASD closure: Deployment, techniques, equipment. J Interv Cardiol 2001;14:69-76. (Pubitemid 32216238)
21. Law MA, Josey J, Justino H, Mullins CE, Ing FF, Nugent AW. Long-term follow-up of the STARFlex device for closure of secundum atrial septal defect. Cath Cardiovasc Interv 2009;73:196.
22. Mullen MJ, Hildick-Smith D, De Giovanni JV, Duke C, Hillis WS, Morrison WL, Jux C. BioSTAR Evaluation Study (BEST): A prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts. Circulation 2006;114:1962-1967. (Pubitemid 44665391)
23. Jux C, Bertram H, Wohlsein P, Bruegmann M, Paul T. Interventional atrial septal defect closure using a totally bioresorbable occluder matrix: Development and preclinical evaluation of the BioSTAR device. J Am Coll Cardiol 2006;48:161-169. (Pubitemid 43929219)
24. Mullen MJ, Devellian CA, Jux C. BioSTAR bioabsorbable septal repair implant. Expert Rev Med Devices 2007;4:781-792
25. Hoehn R, Hesse C, Ince H, Peuster M. First experience with the Biostar-device for various applications in pediatric patients with congenital heart disease. Cath Cardiovasc Interv 2010;75:72-77.
26. (R) [German]. Rofo 2002;174:1387-1394.
27. Delaney JW, Chan KC, Rhodes JF Jr. The design and deployment of the HELEX septal occluder. Cong Heart Dis 2006;1:202-209.
28. Rao PS, Langhough R. Relationship of echocardiographic, shunt flow, and angiographic size to the stretched diameter of the atrial septal defect. Am Heart J 1991;122:505-508.